Please login to the form below
treatment access
This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.
Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
will ensure that patients needing third-line treatment will continue to have access to CAR T-cell therapy. ... will mean that healthcare professionals in these centres will have this treatment as an important option for their patients.”.
Latest news
-
EC launches cancer imaging initiative to accelerate innovation and early diagnosis
With a total of 4bn being earmarked for actions addressing cancer, the plan is divided into four key areas: prevention, early detection, better access to treatment, and improved quality of life ... As part of the plan’s prevention goals, the EC is
-
Genomics England receives government funding for cutting-edge genomics research
rare genetic diseases and patients with cancer to benefit from earlier diagnosis and faster access to treatment. ... The potential for genomics to revolutionise the way we deliver healthcare is great – if we can detect treatable illnesses earlier and
-
PMEA 2022: a celebration of excellence in healthcare marketing
high price medications’, offering hope and support to families who had otherwise not been able to access other available treatment options.
-
WHO calls for leaders to address the global HIV response
According to WHO’s website, of the 38 million people living with HIV, 5.9 million people who know they have HIV are not receiving treatment, while a further four million ... able to access this treatment worldwide in 2021.
-
Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations
Each day in 2021 around 850 children became infected with HIV and approximately 301 died from AIDS-related causes, mainly due to inadequate access to HIV care and treatment services, Gilead ... He continued: “Additional therapy choices help to ensure
More from news
Approximately 1 fully matching, plus 270 partially matching documents found.
Latest Intelligence
-
Meeting healthcare’s rising challenges
An impressive achievement, but this is just base camp in the journey to conquer global issues of poor health, inequality in access to treatment, affordability and ensuring that scientific advances in ... Both technology and data will improve access to
-
Maintaining continuity of care in Ukraine as conflict continues
In response to the need for continued access to treatment, pharma companies have offered aid through direct financial support, as well as the supply of life-saving medicines. ... With the help of WHO, Roche has shipped packs of antibiotics and batches of
-
Patient support programmes: providing meaningful care when you dare to treat rare
specific devices, such screen readers, which may be used to access the PSP. ... Creating a direct avenue for advocacy, from both patient and HCP standpoints, drawing in key opinion leaders involved in enhancing knowledge and advocating for access to
-
The benefits of patient support programmes in specific disease areas
For patients with rare diseases, where information is often scarce, being given access to trusted resources for disease education is so important. ... condition. Managing patients virtually using PSPs could potentially improve this by giving access to
-
EU cross-border healthcare
Patients whose very survival depends on therapies that can only be delivered abroad must face a flurry of challenges to access the treatment that will hopefully change their lives forever. ... Furthermore, both pathways are impacted by several challenges
More from intelligence
Approximately 1 fully matching, plus 58 partially matching documents found.
Latest appointments
-
UN names special envoy for HIV/ AIDS in Africa
Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
-
Basilea's Hans Christian Rohde takes up commercial role at uniQure
access to this crucial treatment to as many patients as possible.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Breaking the silence: It’s time to talk about the menopause
open up the conversation, encouraging women to demand better access to care and treatment, rather than suffer in silence. ... any barriers that need to be overcome, in order to help clients to tailor treatment in a meaningful way.
-
Can Artificial Intelligence Solve the Healthcare Crisis?
In the United Kingdom (UK), NHS waiting lists continue to grow, impacting patients’ access to timely diagnosis and treatment. ... As eye scans are currently examined by specialists, it can be a slow process and possibly preclude early treatment.
-
Actionable Insights for Medical Affairs: Elusive or Within Reach?
Further, market assessment tools, including online surveys, can reveal practice patterns and identify healthcare disparities and barriers to healthcare such as access to treatment. ... Clearly articulate clinical and economic value to build trust with
-
The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. ... step. From the research and development stage all the way to patient access and
-
Be Patient
Trust is paramount because clinical trials are often for not-yet-proven treatments, but for some people taking part in a trial, it is their only option to access treatment not
More from PMHub
Approximately 0 fully matching, plus 41 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU outlines measures to mitigate antibiotic shortage across Europe
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Merging global and local pharmacovigilance operations into a successful integrated approach
PMHub
KVA
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
